Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Akero Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
AKRO is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 5
- −255 vs. Q3 2025
- Shares held
- 20.6K
- −91.3M (−100.0%) vs. Q3 2025
- Total value
- $533.0K
- −$4.34B (−100.0%) vs. Q3 2025
- New holders
- 1
- 2 more added
- Sold out
- 256
- 1 more reduced
5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 20,000 | $532.0K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 18 | $984 | 0.00% | +9+100.0% | Added |
| GAMMA Investing LLC | 452 | $0 | 0.00% | +83+22.5% | Added |
| Bessemer Group Inc | 98 | $0 | 0.00% | −96−49.5% | Reduced |
| Keating Financial Advisory Services, Inc. | 28 | $0 | 0.00% | +28 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −6,280,305−100.0% | Sold out |
| General Atlantic LLC | 0 | $0 | 0.00% | −5,733,989−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −5,702,634−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −5,477,561−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −4,526,920−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −4,251,861−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −4,000,978−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −3,955,555−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −3,809,859−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −3,414,306−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −2,389,314−100.0% | Sold out |
| Alkeon Capital Management LLC | 0 | $0 | 0.00% | −1,850,934−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,785,586−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −1,689,629−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,663,339−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,297,438−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −1,217,044−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,200,000−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,135,766−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,079,657−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −1,058,776−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −1,055,186−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −926,441−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −855,766−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −810,568−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −747,818−100.0% | Sold out |
| Long Focus Capital Management, LLC | 0 | $0 | 0.00% | −720,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −685,842−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −663,442−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −643,636−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −639,598−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −626,526−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −626,019−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −612,126−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −527,175−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −526,200−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −502,913−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −487,230−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −486,000−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −475,400−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −473,625−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −435,293−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −434,689−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −418,975−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −409,539−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −397,010−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −378,858−100.0% | Sold out |
| Summit Partners Public Asset Management, LLC | 0 | $0 | 0.00% | −377,152−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −366,784−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −339,922−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −338,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −335,678−100.0% | Sold out |
| University of Wisconsin Foundation | 0 | $0 | 0.00% | −328,504−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −325,132−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −324,630−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −303,814−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −291,593−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −288,970−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −248,079−100.0% | Sold out |
| Foresite Capital Management VI LLC | 0 | $0 | 0.00% | −244,900−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −237,908−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −236,089−100.0% | Sold out |
| B Group, Inc. | 0 | $0 | 0.00% | −232,446−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −230,600−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −228,884−100.0% | Sold out |
| Eagle Health Investments LP | 0 | $0 | 0.00% | −226,400−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −215,372−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −207,692−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −206,854−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −206,771−100.0% | Sold out |
| Yiheng Capital Management, L.P. | 0 | $0 | 0.00% | −191,076−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −189,194−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −188,844−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −185,559−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −180,016−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −178,549−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −164,529−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −149,200−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −145,609−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −142,247−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −139,366−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −134,837−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −132,817−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −123,352−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −121,477−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −121,410−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −118,100−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −110,747−100.0% | Sold out |
| Nan Fung Trinity (HK) Ltd | 0 | $0 | 0.00% | −110,650−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −110,079−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −108,100−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −103,848−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −103,239−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −99,917−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −97,251−100.0% | Sold out |